Search Results 551-560 of 18322 for alopecia
... alopecia and amenorrhea/menstrual disorders which can be any grade and peripheral neuropathy which must be CTCAE Grade ≤2). Cohort 1 only: 7. Patient is ...
... alopecia, radiation tissue fibrosis, or peripheral neuropathy) * Known allergies, hypersensitivity, or intolerance to JNJ-69086420 or its excipients and ...
... alopecia, peripheral neuropathy and ongoing endocrinopathies controlled on appropriate replacement therapy * Have significant cardiovascular disease defined ...
Any unresolved toxicity NCI CTCAE Grade ≥ 2 from previous anticancer therapy; with the exception of vitiligo and alopecia. Participating Mayo Clinic ...
... alopecia and neuropathy - Patients who are receiving any other investigational agents - History of allergic reactions attributed to compounds of similar ...
... alopecia) and/or complications from prior surgical intervention within 7 days before starting study treatment. Radiation therapy administered within 2 weeks ...
Alendronate and cholecalciferol combination is used to treat osteoporosis (thinning of the bone) in women after menopause. This medicine may also be used to ...
Lichen sclerosus, Lichen planus, Skin wrinkles, Vulvar disorder, Acne, Alopecia areata, Melasma, Age spots, UV skin damage, Rosacea, Canker sores, Actinic ...
... alopecia, or peripheral neuropathy up to grade 2 - Any major surgery =< 4 weeks prior to registration - Any serious and/or unstable pre-existing medical ...
... alopecia * Platelet count >= 20,000/mm\^3 (obtained =< 14 days prior to pre-registration) * Total bilirubin =< 1.5 x upper limit of normal (ULN) (=< 3 x ULN ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Hurry to 3X your gift’s impact on cancer research and care!